NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 2.7100
- +0.0500+1.88%
Close Feb 26 16:00 ET
183.16MMarket Cap-1.82P/E (TTM)
2.7600High2.6440Low403.15KVolume2.6800Open2.6600Pre Close1.09MTurnover0.84%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.56P/B130.35MFloat Cap2.360052wk Low--Dividend TTM48.10MShs Float85.0000Historical High--Div YieldTTM4.36%Amplitude0.0300Historical Low2.7000Avg Price1Lot Size
About Perspective Therapeutics Company
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Company Profile
SymbolCATX
Company NamePerspective Therapeutics
Listing DateApr 19, 2007
Founded1983
CEOMr. Johan M. Spoor
MarketAMEX
Employees119
Fiscal Year Ends12-31
Address2401 Elliott Avenue,Suite 320
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98121
Phone1-206-676-0900
Company Executives
- Name
- Position
- Salary
- Johan M. Spoor
- Director and Chief Executive Officer
- 1.46M
- Juan Graham
- Chief Financial Officer
- --
- Jonathan R. Hunt
- Chief Accounting Officer
- 1.17M
- Dr. Markus Puhlmann, M.D.,PhD
- Chief Medical Officer
- 900.09K
- Lori A. Woods
- Chairman of the Board
- 671.73K
- Dr. Frank Morich, M.D.,PhD
- Independent Director
- 320.06K
- Heidi Henson, C.P.A.
- Independent Director
- 390.70K
- Robert Froman Willian, III
- Independent Director
- 320.06K